EYPT

#1999
EyePoint, Inc. - Common Stock
13.5 8 USD
+0.59%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
13.58
13.58
Faixa anual
0.12
19.01
Mudança diária
+0.59%
Mudança mensal
+4.38%
Mudança em 6 meses
-7.37%
Mudança anual
+13.17%
Fechamento anterior
13.5 0
Open
13.5 8
Mínimo
13.5 8
High
13.5 8
Volume
145
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.14 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-5.76
Índice preço/fluxo de caixa
0.04

EyePoint, Inc. - Common Stock

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Notícias